Treatment of Anal Fistula

Initial Assessment and Treatment

• The American College of Surgeons recommends performing examination under anesthesia (EUA) to accurately define fistula anatomy and rule out abscess, with a high success rate 1, 2
• The American Gastroenterological Association suggests obtaining contrast-enhanced pelvic MRI as the initial imaging procedure, or endoscopic anorectal ultrasound if rectal stenosis is excluded, to evaluate fistula anatomy 1, 2
• Proctosigmoidoscopy should be performed to evaluate for concomitant rectal inflammation, which critically affects treatment decisions and prognosis, with a significant impact on patient outcomes 1, 2
• Draining any associated abscess first is crucial, as more than two-thirds of patients with fistulas have an abscess that must be drained before definitive intervention, to reduce the risk of complications 2

Treatment Algorithm Based on Fistula Anatomy

• For simple low fistulas, the American Society of Colon and Rectal Surgeons recommends performing fistulotomy, with healing rates approaching 100%, and laying open the primary tract and any side tracts 1, 3, 4
• For complex fistulas involving significant sphincter muscle, the European Society of Coloproctology suggests placing a loose, non-cutting seton as the primary treatment, to establish drainage and prevent abscess formation, with a success rate of up to 98% 1, 3, 4, 5, 6
• The use of ligation of intersphincteric fistula tract (LIFT) has a success rate of 53% in Crohn's disease and 77% in cryptoglandular fistulas, while advancement flap has success rates of 61-66% in Crohn's disease patients and 64-80% overall 1, 3, 4

Absolute Contraindications to Fistulotomy

• The American College of Surgeons states that fistulotomy should never be performed in cases of active proctitis or rectosigmoid inflammation, Crohn's Disease Activity Index >150, evidence of perineal Crohn's disease involvement, or anterior fistulas in female patients, due to the high risk of complications 1, 2, 3, 4, 7

Critical Pitfalls to Avoid

• The European Society of Coloproctology warns against using cutting setons, as they result in incontinence rates up to 57% and keyhole deformity, and against probing aggressively for fistula tracts during initial examination, as this creates iatrogenic complexity 1, 5, 6, 7

Special Considerations for Crohn's Disease

• The American Gastroenterological Association recommends controlling sepsis first with loose seton placement, initiating medical therapy with antibiotics and seton drainage, and maintaining therapy with thiopurines, infliximab, or adalimumab, to induce and maintain remission 2, 4
• Seton removal timing should be based on clinical assessment, with the seton kept in place until at least the induction phase of anti-TNF therapy is completed, approximately one month 7

Timing of Definitive Treatment

• The American Society of Colon and Rectal Surgeons suggests that for simple fistulas without proctitis, immediate fistulotomy is appropriate, while for complex fistulas or those with proctitis, seton drainage should be maintained until inflammation resolves, then consider sphincter-preserving techniques 1, 2

Surgical Approaches for Fistula Treatment

Introduction to Fistula Surgery

• The American Gastroenterological Association recommends considering the trade-offs between fistulotomy and sphincter-preserving techniques, including the risk of permanent cosmetic deformity and the potential for lower success rates with sphincter-preserving approaches 8

Sphincter-Preserving Techniques

• The LIFT procedure preserves tissue architecture and normal appearance, with success rates of 53% in Crohn's disease patients and 77% in cryptoglandular fistulas, and is associated with lower continence risk in theory 8
• The American Society of Colon and Rectal Surgeons suggests that advancement flap procedures can close the internal opening with a mucosal flap, leaving external skin intact, with success rates of 61-66% in Crohn's disease and 64-80% overall 8, 9
• Seton drainage alone can be definitive treatment in 13.6-100% of cases when combined with medical therapy, particularly in Crohn's disease, without creating permanent tissue defects 9

Fistulotomy

• The European Society of Coloproctology notes that fistulotomy has near 100% healing rates for simple, low fistulas, but is associated with a 10-20% risk of continence disturbances and permanent cosmetic deformity 10, 11

Comparison of Surgical Approaches

• The American College of Gastroenterology recommends balancing the advantages and disadvantages of fistulotomy and sphincter-preserving techniques, including the risk of recurrence and the potential for lower success rates with sphincter-preserving approaches 8, 10, 11

Post-Fistulotomy Care and Management

Warning Signs and Complications

• The American Gastroenterological Association recommends seeking urgent evaluation if patients develop fever or systemic symptoms indicating spreading infection 12

Critical Management During Healing

• The European Crohn’s and Colitis Organisation suggests that the wound must heal from the inside out, as premature surface closure leads to recurrence 12

Recurrence and Complexity of Perianal Fistulas After Apparent Healing

Mechanisms of Recurrence

• Recurrence after apparent healing often reflects incomplete initial tract closure rather than formation of a brand‑new fistula tract, indicating that deeper tissue healing lagged behind surface closure. 13
• Approximately one‑third of patients develop a new perianal fistula after drainage of an anorectal abscess, with younger individuals (under 40 years) at especially high risk. [14][13]
• The average interval from documented healing to fistula recurrence can extend up to 5.25 years, underscoring the long‑term vulnerability of the anatomical pathway. [14][13]

Risk Factors for Recurrence

• Age < 40 years is a significant predictor of fistula formation after abscess drainage. [14][13]
• Paradoxically, patients without diabetes exhibit a higher incidence of post‑drainage fistula development. [14][13]
• In patients with Crohn’s disease, 27 % experience fistula recurrence after the initial wound has healed. 13

Development of Complex Fistula Tracts

• In Crohn’s disease, the prevalence of fistulizing anal disease reaches 92 % among those with colonic involvement and active rectal disease, reflecting a high propensity for tract complexity. [14][13]

Prevention and Management Strategies

• Administration of peri‑operative antibiotics markedly lowers the rate of subsequent fistula formation following surgical intervention. [14][13]
• For Crohn’s patients, combining surgical drainage with anti‑TNF biologic therapy or immunomodulators improves control of underlying inflammation and reduces recurrence risk. 15
• Routine MRI evaluation after apparent external healing can detect persistent internal tract activity, allowing early therapeutic adjustment before clinical recurrence becomes evident. 15

Imaging and Long‑Term Follow‑Up

• Long‑term surveillance is essential because recurrences may appear many years after apparent healing; the mean time to recurrence reported in series is 5.25 years. [14][13]

Management of Post‑Fistulotomy Complications

Complication Prevalence

• More than two‑thirds of patients with anal fistulas develop associated abscesses that require surgical drainage. [16][17]
• In patients with fistulas who also have Crohn’s disease, active proctitis or luminal inflammation can impede normal healing and precipitate late inflammatory flares. [16][17]
• Active luminal Crohn’s disease should be treated concurrently with fistula management to improve outcomes. 16

Diagnostic Evaluation

• Contrast‑enhanced pelvic MRI is recommended as the first‑line imaging modality to detect fistula tract inflammation, fluid collections, or abscess formation. 18
• Combining MRI findings with clinical assessment is advised to monitor improvement or recurrence of fistula tract inflammation. [16][17]
• Proctosigmoidoscopy should be performed to assess for concurrent rectal inflammation, which significantly influences prognosis and treatment decisions. 18
• While routine clinical assessment for decreased drainage may be adequate in stable patients, imaging is warranted when new symptoms such as tenderness, warmth, or swelling appear. [16][17]

Therapeutic Interventions

• For complex fistulas or identified abscesses, surgical drainage together with placement of a loose seton is mandatory. [16][17]19
• The preferred medical adjunct to seton placement is a combination of antibiotics (e.g., metronidazole and/or ciprofloxacin). [16][17]
• When active Crohn’s disease is present, therapy should be initiated or optimized with immunomodulators (thiopurines) or biologics (infliximab or adalimumab). [16][17]19